2.7.8.11	1-stearoyl-2-arachidonoylphosphatidylinositol + CMP	-	Mus musculus	CDP-1-stearoyl-2-arachidonoylglycerol + myo-inositol	-	r	359924	
2.7.8.11	2-deoxy-CDP-diacylglycerol + myo-inositol	-	Homo sapiens	CMP + ?	-	r	359915	
2.7.8.11	2-deoxy-CDP-diacylglycerol + myo-inositol	optimal activity is 25% higher then with CDP-diacylglycerol	Homo sapiens	CMP + ?	-	r	359915	
2.7.8.11	2-deoxy-CDP-diacylglycerol + myo-inositol	maximal activity only 36% of the optimal activity reached with CDP-diacylglycerol	Candida albicans	CMP + ?	-	r	359915	
2.7.8.11	CDP-1-arachidonoyl-2-stearoylglycerol + myo-inositol	6% of the activity with CDP-1-stearoyl-2-oleoylglycerol	Cavia porcellus	CMP + 1-arachidonoyl-2-stearoylphosphtidylinositol	-	r	359925	
2.7.8.11	CDP-1-stearoyl-2-arachidonoylglycerol + myo-inositol	4% of the activity with CDP-1-stearoyl-2-oleoylglycerol	Cavia porcellus	CMP + 1-stearoyl-2-arachidonoylphosphatidylinositol	-	r	359923	
2.7.8.11	CDP-1-stearoyl-2-oleoylglycerol + myo-inositol	-	Cavia porcellus	CMP + 1-stearoyl-2-oleoylphosphatidylinositol	-	r	359919	
2.7.8.11	CDP-diacylglycerol + 1D-chiro-inositol	conversion of 30.9% CDP-diacylglycerol (utilization significant compared to background, p: 0.05), microsomal fraction, 30°C, 20 min	Tetrahymena vorax	CMP + phosphatidyl-1D-chiro-inositol	-	?	400628	
2.7.8.11	CDP-diacylglycerol + 1L-chiro-inositol	conversion of 25.1% CDP-diacylglycerol (non-significant), microsomal fraction, 30°C, 20 min	Tetrahymena vorax	CMP + phosphatidyl-1L-chiro-inositol	-	?	400629	
2.7.8.11	CDP-diacylglycerol + allo-inositol	83% of the activity on myo-inositol	Tetrahymena vorax	CMP + phosphatidyl-allo-inositol	-	?	388298